China Traditional Chinese Medicine Holdings Co. Limited (0570.HK)
HKD 2.31
(-0.86%)
HKD 2.31
(-0.86%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 37.06 Billion CNY | 4.07% |
| 2022 | 35.61 Billion CNY | -2.11% |
| 2021 | 36.38 Billion CNY | 9.98% |
| 2020 | 33.08 Billion CNY | 1.89% |
| 2019 | 32.47 Billion CNY | 7.22% |
| 2018 | 30.28 Billion CNY | 21.71% |
| 2017 | 24.88 Billion CNY | 18.29% |
| 2016 | 21.03 Billion CNY | 15.4% |
| 2015 | 18.22 Billion CNY | 241.89% |
| 2014 | 5.33 Billion CNY | 5.24% |
| 2013 | 5.06 Billion CNY | 228.26% |
| 2012 | 1.54 Billion CNY | 17.52% |
| 2011 | 1.31 Billion CNY | 9.59% |
| 2010 | 1.19 Billion CNY | 13.15% |
| 2009 | 1.05 Billion CNY | 70.93% |
| 2008 | 619.62 Million CNY | 4.65% |
| 2007 | 592.1 Million CNY | -3.43% |
| 2006 | 613.12 Million CNY | -57.05% |
| 2005 | 1.42 Billion CNY | -37.44% |
| 2004 | 2.28 Billion CNY | -5.29% |
| 2003 | 2.4 Billion CNY | -5.5% |
| 2002 | 2.54 Billion CNY | -0.05% |
| 2001 | 2.55 Billion CNY | 0.7% |
| 2000 | 2.53 Billion CNY | -9.49% |
| 1999 | 2.79 Billion CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 37.54 Billion CNY | 1.29% |
| 2024 Q2 | 37.54 Billion CNY | 0.0% |
| 2023 Q3 | 37.06 Billion CNY | -3.51% |
| 2023 Q4 | 37.06 Billion CNY | 0.0% |
| 2023 FY | 37.06 Billion CNY | 4.07% |
| 2023 Q2 | 38.41 Billion CNY | 0.0% |
| 2023 Q1 | 38.41 Billion CNY | 7.85% |
| 2022 Q1 | 37.92 Billion CNY | 4.21% |
| 2022 Q3 | 35.63 Billion CNY | -6.02% |
| 2022 Q4 | 35.61 Billion CNY | -0.05% |
| 2022 FY | 35.61 Billion CNY | -2.11% |
| 2022 Q2 | 37.92 Billion CNY | 0.0% |
| 2021 Q4 | 36.38 Billion CNY | 0.0% |
| 2021 Q1 | 35.6 Billion CNY | 7.6% |
| 2021 Q3 | 36.38 Billion CNY | 2.2% |
| 2021 Q2 | 35.6 Billion CNY | 0.0% |
| 2021 FY | 36.38 Billion CNY | 9.98% |
| 2020 Q2 | 33.93 Billion CNY | 0.0% |
| 2020 Q4 | 33.08 Billion CNY | 0.0% |
| 2020 FY | 33.08 Billion CNY | 1.89% |
| 2020 Q1 | 33.93 Billion CNY | 4.51% |
| 2020 Q3 | 33.08 Billion CNY | -2.51% |
| 2019 Q2 | 31.43 Billion CNY | 0.0% |
| 2019 Q4 | 32.47 Billion CNY | 0.0% |
| 2019 Q3 | 32.47 Billion CNY | 3.3% |
| 2019 Q1 | 31.43 Billion CNY | 3.79% |
| 2019 FY | 32.47 Billion CNY | 7.22% |
| 2018 Q4 | 30.28 Billion CNY | 0.0% |
| 2018 Q1 | 28.44 Billion CNY | 14.31% |
| 2018 FY | 30.28 Billion CNY | 21.71% |
| 2018 Q2 | 28.44 Billion CNY | 0.0% |
| 2018 Q3 | 30.28 Billion CNY | 6.47% |
| 2017 Q4 | 24.88 Billion CNY | 0.0% |
| 2017 Q1 | 23.11 Billion CNY | 9.9% |
| 2017 Q3 | 24.88 Billion CNY | 7.64% |
| 2017 FY | 24.88 Billion CNY | 18.29% |
| 2017 Q2 | 23.11 Billion CNY | 0.0% |
| 2016 Q3 | 21.03 Billion CNY | 9.88% |
| 2016 Q2 | 19.14 Billion CNY | 0.0% |
| 2016 Q1 | 19.14 Billion CNY | 5.03% |
| 2016 Q4 | 21.03 Billion CNY | 0.0% |
| 2016 FY | 21.03 Billion CNY | 15.4% |
| 2015 Q2 | 12.38 Billion CNY | 0.0% |
| 2015 Q4 | 18.22 Billion CNY | -5.1% |
| 2015 FY | 18.22 Billion CNY | 241.89% |
| 2015 Q3 | 19.2 Billion CNY | 55.07% |
| 2015 Q1 | 12.38 Billion CNY | 132.32% |
| 2014 Q2 | 5.19 Billion CNY | 0.0% |
| 2014 FY | 5.33 Billion CNY | 5.24% |
| 2014 Q4 | 5.33 Billion CNY | 0.0% |
| 2014 Q1 | 5.19 Billion CNY | 2.52% |
| 2014 Q3 | 5.33 Billion CNY | 2.65% |
| 2013 Q3 | 5.06 Billion CNY | 122.75% |
| 2013 FY | 5.06 Billion CNY | 228.26% |
| 2013 Q4 | 5.06 Billion CNY | 0.0% |
| 2013 Q2 | 2.27 Billion CNY | -0.75% |
| 2013 Q1 | 2.29 Billion CNY | 48.47% |
| 2012 Q3 | 1.55 Billion CNY | 6.96% |
| 2012 FY | 1.54 Billion CNY | 17.52% |
| 2012 Q2 | 1.45 Billion CNY | 0.0% |
| 2012 Q4 | 1.54 Billion CNY | -0.7% |
| 2011 Q4 | 1.31 Billion CNY | 0.0% |
| 2011 Q2 | 1.19 Billion CNY | 0.0% |
| 2011 FY | 1.31 Billion CNY | 9.59% |
| 2010 Q4 | 1.19 Billion CNY | 0.0% |
| 2010 FY | 1.19 Billion CNY | 13.15% |
| 2010 Q2 | 1.09 Billion CNY | 0.0% |
| 2009 Q4 | 1.05 Billion CNY | 0.0% |
| 2009 FY | 1.05 Billion CNY | 70.93% |
| 2009 Q2 | 1.01 Billion CNY | 0.0% |
| 2008 FY | 619.62 Million CNY | 4.65% |
| 2008 Q4 | 619.62 Million CNY | 0.0% |
| 2007 FY | 592.1 Million CNY | -3.43% |
| 2006 FY | 613.12 Million CNY | -57.05% |
| 2005 FY | 1.42 Billion CNY | -37.44% |
| 2004 FY | 2.28 Billion CNY | -5.29% |
| 2003 FY | 2.4 Billion CNY | -5.5% |
| 2002 FY | 2.54 Billion CNY | -0.05% |
| 2001 FY | 2.55 Billion CNY | 0.7% |
| 2000 FY | 2.53 Billion CNY | -9.49% |
| 1999 FY | 2.79 Billion CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 907.46 Million HKD | -3984.824% |
| Grand Pharmaceutical Group Limited | 22.51 Billion HKD | -64.636% |
| Extrawell Pharmaceutical Holdings Limited | 1.28 Billion HKD | -2779.791% |
| Wai Yuen Tong Medicine Holdings Limited | 2.09 Billion HKD | -1669.279% |
| Qianhai Health Holdings Limited | 478.11 Million HKD | -7652.987% |
| Lee's Pharmaceutical Holdings Limited | 2.89 Billion HKD | -1182.346% |
| Essex Bio-Technology Limited | 2.82 Billion HKD | -1210.967% |
| Tongfang Kontafarma Holdings Limited | 1.72 Billion HKD | -2045.985% |
| PuraPharm Corporation Limited | 843.96 Million HKD | -4292.177% |
| SSY Group Limited | 11.96 Billion HKD | -209.772% |
| JBM (Healthcare) Limited | 1.38 Billion HKD | -2569.29% |
| Jacobson Pharma Corporation Limited | 3.48 Billion HKD | -963.089% |
| China Resources Pharmaceutical Group Limited | 271.69 Billion HKD | 86.357% |